Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes

I Caruana, B Savoldo, V Hoyos, G Weber, H Liu… - Nature medicine, 2015 - nature.com
I Caruana, B Savoldo, V Hoyos, G Weber, H Liu, ES Kim, MM Ittmann, D Marchetti, G Dotti
Nature medicine, 2015nature.com
Adoptive transfer of chimeric antigen receptor (CAR)-redirected T lymphocytes (CAR-T cells)
has had less striking therapeutic effects in solid tumors,, than in lymphoid malignancies,.
Although active tumor-mediated immunosuppression may have a role in limiting the efficacy
of CAR-T cells, functional changes in T lymphocytes after their ex vivo manipulation may
also account for the reduced ability of cultured CAR-T cells to penetrate stroma-rich solid
tumors compared with lymphoid tissues. We therefore studied the capacity of human in vitro …
Abstract
Adoptive transfer of chimeric antigen receptor (CAR)-redirected T lymphocytes (CAR-T cells) has had less striking therapeutic effects in solid tumors,, than in lymphoid malignancies,. Although active tumor-mediated immunosuppression may have a role in limiting the efficacy of CAR-T cells, functional changes in T lymphocytes after their ex vivo manipulation may also account for the reduced ability of cultured CAR-T cells to penetrate stroma-rich solid tumors compared with lymphoid tissues. We therefore studied the capacity of human in vitro–cultured CAR-T cells to degrade components of the extracellular matrix (ECM). In contrast to freshly isolated T lymphocytes, we found that in vitro–cultured T lymphocytes lack expression of the enzyme heparanase (HPSE), which degrades heparan sulfate proteoglycans, the main components of ECM. We found that HPSE mRNA is downregulated in in vitro–expanded T cells, which may be a consequence of p53 (officially known as TP53, encoding tumor protein 53) binding to the HPSE gene promoter. We therefore engineered CAR-T cells to express HPSE and showed their improved capacity to degrade the ECM, which promoted tumor T cell infiltration and antitumor activity. The use of this strategy may enhance the activity of CAR-T cells in individuals with stroma-rich solid tumors.
nature.com